Impact of smart watch mobile application on the risk treatment of type 2 diabetes mellitus (iSMART-DM).
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 41145321.
- Also identified by DOI 10.1016/j.pcd.2025.10.008.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Mobile health (mHealth) interventions incorporating smartwatches and personalized coaching show promise in improving diabetes self-management. Although studies report modest glycemic benefits and behavioral improvements from app-based interventions, real-world data from East Asian populations remain limited. To evaluate the effectiveness of a smartwatch-based, app-linked lifestyle intervention (iSMART-DM) in improving glycemic control and self-care behavior in patients with non-insulin-treated type 2 diabetes mellitus (T2DM). In a 12-week, open-label randomized controlled trial, 80 adults with T2DM were randomized in a 2:1 ratio to an intervention group (n = 54; smartwatch + mobile app + structured education) or a control group (n = 26; structured education alone). The primary endpoint was the change in glycated hemoglobin (HbA1c). Secondary endpoints included fasting plasma glucose (FPG), HbA1c target attainment (<6.5 %), and changes in self-care behavior scores using the Summary of Diabetes Self-Care Activities Questionnaire (SDSCA-K). Satisfaction and adherence to the digital health intervention were also assessed. After 12 weeks, the mean HbA1c change was -0.14 % and -0.13 % in the intervention and control groups, respectively (p = 0.837). No significant differences were observed in FPG change or HbA1c target attainment. However, the intervention group showed significantly greater improvement in SDSCA-K scores (+9.7 points; 95 % CI 4.0-15.6; p = 0.001), particularly in diet and physical activity. User satisfaction with the mobile platform was high, with > 85 % reporting a positive effect on daily health management. Although short-term glycemic control showed no significant difference, the smartwatch-based mobile intervention significantly enhanced self-care behaviors in patients with T2DM. These findings highlight the behavioral benefits of wearable-integrated mHealth platforms and support their broader application in lifestyle modification strategies.
Medical subject headings
- Diabetes Mellitus, Type 2
- Mobile Applications
- Blood Glucose
- Glycemic Control
- Risk Reduction Behavior
- Telemedicine
- Blood Glucose Self-Monitoring